Forex News
Revolutionizing Payments: iVendpay Unveils the First-Ever NFC Cryptocurrency Technology
Breaking Boundaries in Digital Payments It is with great excitement that we announce ivendPay’s latest innovation – the world’s first cryptocurrency payment technology via NFC (Near Field Communication). This groundbreaking advancement is set to revolutionize the way we make digital payments, setting a new standard for convenience, security, and efficiency. Unparalleled Technology With the introduction…
Beijing Stock Exchange Urges Major Shareholders to Hold Steady: Report
The Future of Funding for Innovative Small Companies Redefining the Bourse Landscape As a bit of background, the bourse was only conceived two years ago and is mainly used to facilitate funding for “little giants” i.e. innovative small companies. It has faded into obscurity somewhat though amid a lack of investor interest. Nonetheless, ‘major shareholders’…
Say Goodbye to COPD Exacerbations: Dupixent (Dupilumab) Proves Effective in Second Phase 3 Trial, Speeding Up FDA Approval and Paving the Way to Becoming the First Biologic Treatment for COPD
Dupixent® (dupilumab) Significantly Reduced COPD Exacerbations in Second Positive Phase 3 Trial Breaking News: Cutting Edge Treatment for COPD In a recent study, the NOTUS trial has shown that Dupixent® has met its primary endpoint with overwhelming efficacy in reducing exacerbations in patients with moderate-to-severe COPD. This breakthrough treatment has shown a 34% reduction in…
Conquering Resistance: AUD/USD’s Battle to Begin the Week – A Heartfelt Update
Embracing Change: A Look at the AUD/USD Daily Chart Trading Analysis The AUD/USD pair has been showing some interesting movements on the daily chart recently. Today, the pair is trading relatively unchanged, reaching a high of 0.6595 before pulling back to 0.6570 levels. The 200-day moving average (blue line) at 0.6582 is serving as a…
Revolutionizing Cancer Treatment: The Incredible Power of Engeneics’ Nanocell Drug Conjugate for Pancreatic Cancer Patients
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer SYDNEY and NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — EnGeneIC, a pioneer in personalised cancer therapeutics, announces the publication of its clinical trial results in peer reviewed prestigious journal “Clinical Cancer Research”, published by the American Association for Cancer Research….
Secure Your Investment: Rosen, a Trusted Law Firm, Urges Brainstorm Cell Therapeutics Inc. Investors to Seek Counsel Before Securities Class Action Deadline
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BCLI NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between…
US Navy Rescues Hijacked Tanker in Middle East Waters: A Triumph at Sea
The Rescue of the Central Park: A Maritime Success Story Overview In a bold display of international cooperation and maritime security, a US Navy ship, assisted by a Japanese destroyer, the USS Mason, responded to a distress call from a commercial tanker in Middle Eastern waters. The Central Park, a small chemical tanker carrying a…
Act Now: Protect Your Investment with PureCycle Technologies, Inc. – A Deadline Reminder from Rosen, a Trusted Law Firm
Introduction In a recent announcement dated November 26, 2023, the Rosen Law Firm has issued a reminder to investors of PureCycle Technologies, Inc. regarding an important lead plaintiff deadline. The deadline is set for November 28, 2023, and affects individuals who purchased securities of PureCycle Technologies, Inc. between August 8, 2023, and September 13, 2023,…